Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/25/2003US20030180846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180845 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180844 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180843 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180842 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180841 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180840 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180839 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180838 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180837 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180836 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180835 Contacting the glycopeptide with a reaction mixture that contains a fucose donor group and first fucosyltransferase to transfer fucose from fucose donor group to the acceptor group, such glycopeptide has a uniform fucosylation pattern
09/25/2003US20030180822 Detection of erythropoietin and erythropoietin receptor
09/25/2003US20030180820 Tests for the rapid evaluation of ischemic states and kits
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180816 Method to provide bacterial ghosts provided with antigens
09/25/2003US20030180813 Method of screening remedy for diabetes
09/25/2003US20030180812 Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180798 Analyzing second messenger sigalling activity; drug screening
09/25/2003US20030180796 Fibroblast/epidermal growth factors; PRO polypeptides
09/25/2003US20030180795 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180793 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180792 Fusion proteins; PRO polypeptides; fibroblast/nerve growth factor receptors
09/25/2003US20030180791 Anti-proliferation domain of human Bcl-2 and DNA encoding the same
09/25/2003US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180784 For modulating the growth and/or differentiation of (endothelial) cells; drug screening
09/25/2003US20030180764 Genes affected by cholesterol treatment and during adipogenesis
09/25/2003US20030180763 Amplifying isolated nucleic acids from the sample containingpart or all of exon 2 and/or part or all of exon 3 of alleles obtained from the sample using a suitable pair of primers and analyzing amplification of nucleic acid
09/25/2003US20030180760 Isolated nucleic acid sequences and polypeptides encoded thereby for epothilone B hydroxylase and mutants and variants and ferredoxin or variants or mutants
09/25/2003US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen
09/25/2003US20030180753 Full length human hcn1ih channel subunit and variants
09/25/2003US20030180752 Type 2 cytokine receptor and nucleic acids encoding same
09/25/2003US20030180751 A polypeptides involved in the lignin, tannin and fructan biosynthetic pathways, and a preferred polynucleotides encoding such polypeptide
09/25/2003US20030180750 Treatment of cancer and neurological diseases
09/25/2003US20030180745 Novel nucleic acids and polypeptides
09/25/2003US20030180744 High affinity oligonucleotide ligands to growth factors
09/25/2003US20030180739 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180733 Contacting a sample containing a bacterial nucleic acid with a probes or primers and detecting the presence and/or amount of hybridized probes and/or amount of bacterial species
09/25/2003US20030180728 Differentially regulated in breast cancer
09/25/2003US20030180726 Compositions and methods relating to ovarian specific genes and proteins
09/25/2003US20030180723 Cloning of novel gene sequences expressed and repressed during winter dormancy in the apical buds of tea ( Camellia sinensis L. (O.) Kuntze) bush
09/25/2003US20030180722 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
09/25/2003US20030180715 Methods and means for assessing HIV envelope inhibitor therapy
09/25/2003US20030180712 Host cells transfected with a recombinant expression vector containing nucleic acid control sequences operatively linked to an L-type Ca2+ channel beta 3 gene; host cell free of functional beta 3 subunit-containing L-type Ca2+ channels
09/25/2003US20030180706 Removal of prions from blood, plasma and other liquids
09/25/2003US20030180416 Carbohydrate oxidase and use thereof in baking
09/25/2003US20030180330 Method for identifying helicobacter antigens
09/25/2003US20030180329 Induction nucleic acids into cell; forming vaccine
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180324 Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use
09/25/2003US20030180322 Genome segments; detection of phenotype
09/25/2003US20030180320 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries
09/25/2003US20030180317 Diagnosis ear infections in children
09/25/2003US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
09/25/2003US20030180314 Genetic engineering polypeptide; culture product
09/25/2003US20030180313 Genetic engineering; detection of humans immunodeficiency virus infections
09/25/2003US20030180312 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180311 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors
09/25/2003US20030180310 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors
09/25/2003US20030180309 Autoimmune disease; antiinflammatory agents; antiallergens; antihistamines; d
09/25/2003US20030180308 Deglycosylated ricin toxin a-chain vaccine
09/25/2003US20030180307 Polypeptides; detecting infections using antibodies
09/25/2003US20030180306 Controlling cell differentiation; muscular disorders
09/25/2003US20030180303 Lipopolysaccharide binding protein derivatives
09/25/2003US20030180301 Prevention organ rejection; induction immunology response; reduce fibrosis
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180299 Cardiovascular disorders
09/25/2003US20030180298 Genetic engineering; using nucleic acid for cancer diagnosis
09/25/2003US20030180297 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
09/25/2003US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
09/25/2003US20030180284 Monoclonal antibodies; vaccines
09/25/2003US20030180275 Human serpin polypeptides
09/25/2003US20030180266 Methods of expressing LIM mineralization protein in non-osseous cells
09/25/2003US20030180257 Alphavirus vectors for paramyxovirus vaccines
09/25/2003US20030180256 Cytokine-like proteins
09/25/2003US20030180255 IL-17 homologous polypeptides and therapeutic uses thereof
09/25/2003US20030180225 Walnut and ryegrass allergens
09/25/2003CA2799805A1 Optimizing glycan processing in plants
09/25/2003CA2481399A1 Peptides and pharmaceutical compositions comprising said peptides for treating cancer
09/25/2003CA2479307A1 Virus like particle from papillomavirus and their use in vaccine
09/25/2003CA2479304A1 Virus-like particles of human papillomavirus
09/25/2003CA2479246A1 Method for overexpression of zwitterionic polysaccharides
09/25/2003CA2479154A1 Novel genes
09/25/2003CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003CA2479007A1 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner
09/25/2003CA2478962A1 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003CA2478878A1 Identifying peptide modifications
09/25/2003CA2478808A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003CA2478790A1 Polypeptides binding to human syntaxin 1a
09/25/2003CA2478692A1 Engineered baculoviruses and their use
09/25/2003CA2478651A1 Method of inducing an enhanced immune response against hiv
09/25/2003CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
09/25/2003CA2477911A1 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
09/25/2003CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
1 ... 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 ... 2916